NDATOPICALOINTMENT
Approved
Dec 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
ULTRAVATE (halobetasol propionate) by PharmaIN is signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in plaque psoriasis is unknown. Approved for psoriasis. First approved in 1990.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ULTRAVATE (halobetasol propionate) is a topical ointment corticosteroid indicated for plaque psoriasis. It works through signaling, immune function, inflammation, and protein regulation, though the precise mechanism in psoriasis remains unknown. This is a high-potency Class I topical steroid approved in 1990.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting team consolidation and focus on retention strategies rather than expansion.
Mechanism of Action
signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in plaque psoriasis is unknown.
Indications (1)
Clinical Trials (2)
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Started Nov 2020
22 enrolled
Palmoplantar PsoriasisPlaque Psoriasis
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
Started Apr 2016
154 enrolled
Psoriasis
Career Relevance
Worked on ULTRAVATE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.